deltatrials
Unknown NA INTERVENTIONAL 1-arm NCT01730651

High Dose Intensity Modulated Radiation Therapy in the Cervical Cancer With Metastatic Lymphadenopathies.

A Phase II Study of High Dose Intensity Modulated Radiation Therapy in the Cervical Cancer With Metastatic Lymphadenopathies at Initial Diagnosis.

Sponsor: Keimyung University Dongsan Medical Center

Interventions Tomotherapy
Updated 10 times since 2017 Last updated: Sep 14, 2020 Started: Jul 13, 2012 Primary completion: Jul 31, 2022 Completion: Jul 31, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01730651, this NA trial focuses on Cervical Cancer and remains ongoing. Sponsored by Keimyung University Dongsan Medical Center, it has been updated 10 times since 2012, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Oct 2017 · 9 months · monthly snapshotRecruiting~Oct 2017 – ~Jun 2018 · 8 months · monthly snapshotRecruiting~Jun 2018 – ~Sep 2019 · 15 months · monthly snapshotRecruiting~Sep 2019 – ~Oct 2020 · 13 months · monthly snapshotActive Not Recruiting~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshotActive Not Recruiting~Jan 2021 – ~Nov 2022 · 22 months · monthly snapshotActive Not Recruiting~Nov 2022 – ~Jul 2024 · 20 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotUnknown~Sep 2025 – present · 10 months · monthly snapshotUnknown

Change History

10 versions recorded
  1. Sep 2025 — Present [monthly]

    Unknown NA

  2. Sep 2024 — Sep 2025 [monthly]

    Unknown NA

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown NA

    Status: Unknown StatusUnknown

  4. Nov 2022 — Jul 2024 [monthly]

    Unknown Status NA

    Status: Active Not RecruitingUnknown Status

  5. Jan 2021 — Nov 2022 [monthly]

    Active Not Recruiting NA

Show 5 earlier versions
  1. Oct 2020 — Jan 2021 [monthly]

    Active Not Recruiting NA

  2. Sep 2019 — Oct 2020 [monthly]

    Active Not Recruiting NA

    Status: RecruitingActive Not Recruiting

  3. Jun 2018 — Sep 2019 [monthly]

    Recruiting NA

  4. Oct 2017 — Jun 2018 [monthly]

    Recruiting NA

    Phase: PHASE2NA

  5. Jan 2017 — Oct 2017 [monthly]

    Recruiting PHASE2

    First recorded

Jul 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Keimyung University Dongsan Medical Center
  • National Cancer Center, Korea
Data source: National Cancer Center, Korea

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations